Diamond market crash is Africa’s opportunity, not its crisis – M'zée Fula Ngenge

Global natural diamond supply is forecast to fall below 95 million carats this year, the lowest since 1987. For Dr. M'zée Fula Ngenge, chairperson of the African Diamond Council (ADC), this is not a death knell but a clarion call. In an exclusive...

Yesterday

Tracr passes 5 million rough diamonds milestone as De Beers expands provenance push

De Beers Group's blockchain-enabled traceability platform Tracr reached a significant milestone in 2025, with more than 5 million rough diamonds individually scanned and registered, up from 2.8 million cumulative registrations reported in 2024. The...

28 september 2026

South African diamonds head to Hong Kong: SDT partners with BRINKS for JGW 2026

South Africa’s State Diamond Trader (SDT) has confirmed the country's participation in Jewellery & Gem World Hong Kong (JGW) 2026 through a partnership with BRINKS. SDT marketing and communication manager Tsholofelo Gopolang Tselapedi...

14 september 2026

David Benderly: PermaScribe seeks to put trust mark on diamond table, not just girdle

In this interview with Rough & Polished’s Mathew Nyaungwa, PhotoScribe Technologies president and chief executive David Benderly explains how PermaScribe differs technically from conventional laser inscription, its potential to strengthen security, and...

31 august 2026

The great reset: Paul Zimnisky on supply catharsis, De Beers' bargain and the case for natural diamonds

The natural diamond industry is in the throes of its most profound reset in a generation. Supply is plunging to its lowest level since 1987 and De Beers—once valued at over $9 billion—is reportedly being sold for as little as $1 billion.
Lab-grown...

10 august 2026

A new Russian drug based on Omega-3 to be tested in the Arctic

17 october 2023

Scientists want to investigate the effect of an increased concentration of substances on the body of residents of the Far North.

Omega-3 is colloquially called fish oil. Scientifically speaking, these are polyunsaturated fatty acids, which are necessary for a person for normal development in childhood, maintaining immunity, protecting the cardiovascular system and other purposes.

The experiment will involve volunteers aged 20 to 50 years who will take capsules of a new Russian drug based on Omega-3 for two months. Scientists will check changes in the body in two groups of people: those who took and those who did not take the drug.

Before that, all participants in the experiment will have their indicators of muscle and fat components of the body, the work of the cardiovascular system, metabolism, respiration and others checked. And the same set of surveys will be carried out at the end of the experiment.

The researchers claim that the drug contains up to 60% Omega-3 fatty acids, which is twice as much as in traditional medicine. The study will help to obtain new scientific data on changes in biochemical parameters in residents of the far North, nia14.ru reports.

Alex Shishlo for Rough&Polished